New COPD drug shows promise in Real-World romanian study

NCT ID NCT06368427

Completed Symptom relief Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 10 people with moderate to severe COPD in Romania who started taking the inhaler TRIXEO AEROSPHERE. Researchers measured changes in their health status and treatment satisfaction over 3 and 6 months. The goal was to see how the medication works in everyday life, not in a controlled lab setting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Contacts and locations

Locations

Research Site

Baia Mare, Romania
Research Site

Bucharest, Romania
Research Site

Cluj-Napoca, Romania
Research Site

Constanța, Romania
Research Site

Craiova, Romania
Research Site

Deva, Romania
Research Site

Dorohoi, Romania
Research Site

Hunedoara, Romania
Research Site

Iași, Romania
Research Site

Luduş, Romania
Research Site

Medgidia, Romania
Research Site

Oradea, Romania
Research Site

Sighișoara, Romania
Research Site

Suceava, Romania
Research Site

Târgu Mureş, Romania
Research Site

Timișoara, Romania

More trials for these conditions

Other studies related to the condition(s) this trial covers.